Is There Any Limitation of the Study?

A little more than 200 patients were finally evaluated, and only 109 patients with ischemicadomyopathy were actually revascularized. The conclusion of the study are all hypothesis-generating. Future randomized controlled trials involved in this kind of population must be performed once of this question. An important topic was not assessed by theosis, and the topic is viability.